Cancer occurs across virtually every branch of the animal kingdom, from fruit flies to whales, clams to elephants. The disease is not a product of modern human life. It is a fundamental vulnerability of any organism whose cells divide, and wild animals are no exception. What makes the topic fascinating is not whether wild animals get cancer but how rarely we see it, how some species have evolved remarkable defenses against it, and what those defenses might teach us about fighting cancer in ourselves.
Why Wild Cancer Is Hard to Spot
If cancer is so widespread across species, you might wonder why we don’t see tumor-riddled animals stumbling around in nature. The short answer is that wild animals with cancer don’t last long. A sick animal is a slow animal, and a slow animal gets eaten. Research on fruit flies with gut tumors found that cancer-bearing individuals were picked off by hunting spiders far more readily than healthy ones, suggesting that predation acts as a powerful filter that removes cancerous animals from wild populations before tumors have time to progress to advanced stages.1Animal Behaviour. Gut cancer increases the risk of Drosophila being preyed upon by hunting spiders Early-stage tumors show up in wild-caught animals, but metastatic cancers are rare in the field, not because they don’t develop, but because the animal is usually dead from other causes first.
There is also a straightforward observation problem. Nobody is giving wild deer CT scans or running bloodwork on free-swimming fish. Most of what we know about cancer rates in wild species comes from necropsies of animals that washed ashore dead, were brought to rehabilitation centers, or were hunted and examined. That means our data is biased toward species that humans regularly handle or monitor. For the vast majority of the roughly eight million animal species on Earth, we simply have no idea how common cancer is.
Zoo animals offer a partial window into cancer susceptibility because they receive veterinary care and live longer than their wild counterparts, giving tumors more time to develop. Some species show high cancer rates in captivity that they might never reach in nature simply because they would not survive to the age at which tumors appear.2Cancer Discovery. Cancer Prevalence across Vertebrates The same is true for domesticated animals: pets and livestock live longer than feral counterparts and develop cancer at higher rates as a result.3PubMed Central. The epidemiology of cancer in animals
Why Don’t Whales and Elephants Get More Cancer?
You would expect that the biggest animals, with trillions more cells dividing over long lifespans, would be riddled with tumors. A blue whale has roughly a thousand times more cells than a human, and each cell division carries a small chance of a cancer-causing mutation. By sheer probability, large, long-lived animals should have astronomically higher cancer rates. They don’t. This puzzling observation is known as Peto’s paradox, named after the epidemiologist who first pointed it out.4PubMed Central. Peto’s Paradox: evolution’s prescription for cancer prevention
The resolution appears to be that large-bodied species evolved stronger cancer defenses as they grew bigger over evolutionary time. The evidence is clearest in elephants. While humans carry one copy of the tumor-suppressor gene TP53, often called the “guardian of the genome,” African elephants carry at least 20 copies. That expansion happened alongside the evolution of large body size in the elephant lineage and gave elephant cells an unusually sensitive damage-detection system: when their DNA is damaged, elephant cells are more likely to self-destruct than to attempt a risky repair.5PubMed Central. TP53 copy number expansion is associated with the evolution of increased body size and an enhanced DNA damage response in elephants 6PubMed Central. Potential Mechanisms for Cancer Resistance in Elephants and Comparative Cellular Response to DNA Damage in Humans
Bowhead whales, which can live over 200 years, took a different evolutionary path entirely. Rather than stacking extra copies of tumor-suppressor genes, bowhead whale cells appear to have supercharged their DNA repair machinery. Their cells fix double-strand DNA breaks, one of the most dangerous forms of genetic damage, with greater speed and accuracy than cells from other mammals. Researchers identified a protein called CIRBP that is produced at unusually high levels in bowhead tissues and, when introduced into human cells, improved both major DNA-repair pathways and reduced mutation rates.7PubMed Central. Evidence for improved DNA repair in the long-lived bowhead whale The whale’s strategy is not to kill damaged cells but to faithfully repair them before mutations accumulate.
The Naked Mole Rat’s Unusual Shield
Among smaller animals, the naked mole rat stands out. These wrinkly, nearly hairless rodents live in underground colonies in East Africa and can survive more than 30 years, roughly ten times longer than a mouse. For decades, researchers observed almost no cancer in colonies of thousands of animals, a striking anomaly for a rodent. The explanation turns out to involve hyaluronan, a sugar-based molecule found in the spaces between cells. Naked mole rat cells produce an extremely large version of this molecule, more than five times bigger than the version made by human or mouse cells. This oversized hyaluronan accumulates densely in their tissues because the enzymes that normally break it down are less active.8PubMed Central. High-molecular-mass hyaluronan mediates the cancer resistance of the naked mole rat
Here is the revealing part: when researchers knocked down production of this large hyaluronan, or ramped up the enzymes that degrade it, naked mole rat cells suddenly became susceptible to the same cancer-causing manipulations that transform mouse cells. Remove the shield, and the rodent’s cells behave like any other mammal’s. The hyaluronan appears to act as a physical and signaling barrier that keeps cells from growing out of control.
Cancers That Spread Between Animals
In humans, cancer is not contagious. You cannot catch a tumor from someone else. But in a handful of wild species, cancer cells themselves have become infectious agents, leaping from one animal to another like a parasite. These transmissible cancers are among the strangest phenomena in all of biology.
The most dramatic example is devil facial tumor disease, which has devastated Tasmanian devil populations since the 1990s. The cancer originated in the nerve-sheath cells of a single devil and is transmitted when devils bite each other on the face during mating-season fights. The tumor cells survive the transfer because the devil population has unusually low genetic diversity in the immune-recognition molecules that normally cause tissue rejection. In effect, the cancer cells look enough like “self” that the recipient’s immune system fails to attack them.9PubMed Central. A Devil of a Transmissible Cancer Every tumor sampled from sick devils across Tasmania carries the same distinctive chromosomal rearrangements, confirming that it is a single clonal cell line passed from animal to animal rather than cancers arising independently.10Nature. Transmission of devil facial-tumour disease The disease has killed the majority of the wild devil population, and a second, independently arisen transmissible cancer was later discovered in the same species.11PubMed. Tasmanian devil facial tumor disease: insights into reduced tumor surveillance from an unusual malignancy
Even more surprising, transmissible cancers have been found in marine bivalves. Soft-shell clams along the North American coast harbor a leukemia-like cancer whose cells spread through seawater from one clam to another. Researchers have detected the cancer’s DNA signature in environmental water samples kilometers from infected beds, suggesting these rogue cells can travel considerable distances.12PubMed Central. Atlantic to Pacific: Outbreak of bivalve transmissible neoplasia detected in hybridizing soft-shell clams and eDNA in Puget Sound Bivalve transmissible neoplasia is now recognized as one of at least three broad types of naturally contagious cancer, alongside the Tasmanian devil tumors and canine transmissible venereal tumor in dogs.13PubMed Central. Identification of an Outbreak of Bivalve Transmissible Neoplasia in Soft-Shell Clams (Mya arenaria) in the Puget Sound Using Hemolymph and eDNA Surveys
Pollution, Viruses, and Cancer Hotspots in Nature
While cancer is a background reality for all animals, certain wild populations experience unusually high rates, and the causes often mirror human risk factors: chemical exposure and viral infection.
Beluga whales in the St. Lawrence Estuary of Quebec have been studied since the 1980s and show cancer rates far higher than any other cetacean population. The estimated annual cancer rate in these belugas is comparable to rates seen in humans, including an unusually high incidence of intestinal cancer. The estuary is heavily contaminated with polycyclic aromatic hydrocarbons (PAHs) from nearby aluminum smelters, and the human communities along the same waterway also experience elevated cancer rates linked to the same pollutants.14PubMed Central. Cancer in wildlife, a case study: beluga from the St. Lawrence estuary, Québec, Canada This population serves as a stark case study of how industrial contamination can drive cancer in wild animals just as it does in people.
California sea lions provide another example, though the mechanism is different. Urogenital carcinoma is the most common cancer in marine mammals, and it hits sea lions hard. Research has identified a trio of contributing factors: a sexually transmitted herpesvirus called OtHV1, exposure to persistent organic pollutants, and the animal’s genetic background.15PubMed Central. Common cancer in a wild animal: the California sea lion (Zalophus californianus) as an emerging model for carcinogenesis The virus is found at high concentrations in tumors, and its genome contains suspected cancer-promoting genes, supporting the idea that it plays a direct role in tumor development.16PubMed Central. Unlocking the Role of a Genital Herpesvirus, Otarine Herpesvirus 1, in California Sea Lion Cervical Cancer The parallels with human cervical cancer and HPV are hard to miss.
Green sea turtles face a tumor disease called fibropapillomatosis that causes disfiguring growths on the skin, eyes, and internal organs. It is linked to chelonid alphaherpesvirus 5, which is found at very high concentrations in tumorous tissues.17PubMed. Molecular evolution of fibropapilloma-associated herpesviruses infecting juvenile green and loggerhead sea turtles The disease appears to be both virally and environmentally driven, with outbreaks concentrated in degraded coastal habitats.18Communications Biology. Environmental DNA monitoring of oncogenic viral shedding and genomic profiling of sea turtle fibropapillomatosis reveals unusual viral dynamics The tumors can obstruct a turtle’s vision, feeding, and swimming, making even non-lethal growths a serious threat to survival in the wild.
The Myth That Sharks Don’t Get Cancer
Few misconceptions about animal cancer have been as persistent, or as commercially exploited, as the claim that sharks are immune to the disease. The idea gained wide traction in the 1990s and fueled a multimillion-dollar market for shark cartilage supplements marketed as cancer treatments. The problem is that the premise is flatly wrong. Both malignant and benign tumors have been documented in sharks and their relatives, including cases from the Registry of Tumors in Lower Animals and individual sharks found with two separate cancers each.19PubMed. Shark cartilage, cancer and the growing threat of pseudoscience
Researchers have examined tumor tissues from wild-caught blue sharks and found the same molecular hallmarks of cancer seen in other vertebrates, including upregulation of the same proliferation markers and activation of the same cancer-associated genes (like myc and ras) that drive tumors in mammals.20PubMed. Molecular markers of cancer in cartilaginous fish: immunocytochemical study of PCNA, p-53, myc and ras expression in neoplastic and hyperplastic tissues from free ranging blue sharks, Prionace glauca (L.) The lesions included gastric polyps, testicular tumors, liver tumors, and fibropapillomas. Sharks get cancer, full stop. The fact that we don’t see it more often is likely the same detection problem that applies to most wild species: nobody is routinely screening free-swimming sharks for internal tumors.
Life History and the Trade-Off Between Reproduction and Cancer Defense
One of the more thought-provoking ideas in evolutionary oncology is that cancer susceptibility is not random but is shaped by an animal’s reproductive strategy. Every organism has a limited energy budget, and how it divides that budget between reproduction and bodily maintenance has consequences for cancer. Species that invest heavily in rapid reproduction tend to spend less on the cellular repair and immune surveillance that keeps tumors in check.21PubMed Central. Cancer susceptibility and reproductive trade-offs: a model of the evolution of cancer defences Conversely, long-lived species that reproduce slowly, like elephants and whales, have had strong evolutionary pressure to build robust cancer defenses because a tumor at age 15 would wipe out decades of future reproduction.
A study of cancer across bird species found support for this pattern: species with larger clutch sizes, meaning those that lay more eggs per breeding attempt and invest more in reproduction at once, had significantly higher rates of both tumors and malignant cancers.22PubMed Central. Life history and cancer in birds: clutch size predicts cancer The relationship held even after accounting for body size. This is consistent with the broader evolutionary framework: cancer defense is not free. It competes with reproduction for resources, and natural selection strikes a different balance in every lineage.
Aging itself may be part of this equation. As immune function declines with age, a process biologists call immunosenescence, the body becomes less capable of detecting and destroying aberrant cells. The interplay runs both ways: age-related decline in immune surveillance may allow tumors to take hold, and tumors themselves may accelerate the aging process by increasing the metabolic burden on the body.23Functional Ecology. Eco‐evolutionary perspectives of the dynamic relationships linking senescence and cancer
How Cancer in Wild Animals Affects Ecosystems
Cancer is usually thought of as a problem for the individual animal that has it, but its effects ripple outward. A tumor-bearing animal competes less effectively for food and territory, is more vulnerable to predators, may be a poorer parent, and may disperse less widely. When cancer is common enough in a population, these individual-level effects can influence community dynamics and ecosystem functioning. Researchers have argued that oncogenic phenomena, from precancerous lesions to advanced metastatic disease, represent an underappreciated force shaping predator-prey relationships, competition, pathogen spread, and dispersal patterns in wild populations.24Cell Press (Trends in Ecology & Evolution). Cancer: a missing link in ecosystem functioning?
The Tasmanian devil case illustrates this vividly. The collapse of devil populations from facial tumor disease has triggered cascading ecological changes in Tasmania, because devils were the island’s top marsupial predator. Populations of their prey and smaller competitors have shifted in response. When a disease can remove a top predator from an ecosystem, the consequences extend well beyond the species that carries the tumor.
What Animal Cancer Research Means for Human Medicine
Understanding how evolution solved the cancer problem in diverse species has become a growing area of biomedical interest. If elephants evolved 20 copies of TP53 and that keeps their cells from going haywire, can we mimic that effect pharmacologically in human cells? If bowhead whale CIRBP improves DNA repair when added to human cells, could a drug based on its mechanism reduce mutation accumulation in people? If naked mole rat hyaluronan blocks malignant transformation, could a synthetic version be developed as a preventive therapy?
These are real research directions, not idle speculation. Reviews of the field emphasize that studying the molecular mechanisms behind multiple independent cancer-resistance adaptations across species could yield new approaches to both cancer prevention and treatment in humans.25PubMed Central. Mechanisms of cancer resistance in long-lived mammals The practical challenge is substantial: translating a mechanism that evolved over millions of years in a distantly related species into something that works in the human body is not straightforward. So far, only a handful of the most extensively studied species, primarily elephants and certain rodents, have yielded findings directly informing human oncology research.26PubMed. Analysis of Cancer-Resisting Evolutionary Adaptations in Wild Animals and Applications for Human Oncology A newer approach involves identifying the specific genes under positive selection for cancer resistance in wild species and checking whether humans carry versions of those same genes that could be therapeutically targeted.
The field is still young, and the gap between a fascinating biological discovery and a medicine that works in a clinic is wide. But the diversity of anti-cancer strategies that evolution has already produced, from extra tumor suppressors to oversized sugar molecules to supercharged DNA repair, represents a catalog of solutions that no drug-design program would have invented from scratch. Wild animals are not just getting cancer in the wild. They are also, in many cases, showing us entirely new ways to resist it.